MT-0169

DB17430InvestigationalProtein Based Therapies

MT-0169 is a usion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to a human single chain variable fragment with affinity for human CD38 cell surface protein.

Mechanism: Pharmacologically active on ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
Curator reviewed
Code names: MT-0169 · TAK-169

Resolves to

Targets

P28907CD38

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with MT-0169, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account